CSNVY logo

Corbion N.V. (CSNVY)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Corbion N.V. (CSNVY) with AI Score 38/100 (Weak). Corbion N. V. is a global provider of lactic acid and its derivatives, offering ingredient solutions derived from renewable resources. Market cap: 0, Sector: Basic materials.

Last analyzed: Mar 16, 2026
Corbion N.V. is a global provider of lactic acid and its derivatives, offering ingredient solutions derived from renewable resources. The company serves diverse markets, including food, home and personal care, pharmaceuticals, animal nutrition, medical devices, and bioplastics.
38/100 AI Score

Corbion N.V. (CSNVY) Materials & Commodity Exposure

CEOOlivier Rigaud
Employees2383
HeadquartersAmsterdam, NL
IPO Year2011

Corbion N.V., founded in 1919 and headquartered in the Netherlands, is a global leader in lactic acid-based solutions and other bio-based ingredients. With a focus on sustainability, Corbion serves diverse industries, offering solutions for food, home & personal care, pharmaceuticals, and bioplastics, differentiating itself through renewable resource utilization.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 16, 2026

Investment Thesis

Corbion N.V. presents a notable research candidate due to its leading position in the lactic acid and bio-based ingredients market. The company's focus on sustainability aligns with growing consumer and regulatory demand for environmentally friendly solutions. With a P/E ratio of 14.66 and a dividend yield of 3.37%, Corbion offers a blend of value and income. A key value driver is the increasing adoption of bio-plastics and sustainable food ingredients, which is expected to drive revenue growth in the coming years. The company's ongoing investments in R&D and capacity expansion are expected to further strengthen its competitive position. Potential risks include fluctuations in raw material prices and changes in regulatory policies related to bio-based products.

Based on FMP financials and quantitative analysis

Key Highlights

  • Corbion N.V. has a market capitalization of $1.36 billion, reflecting its significant presence in the specialty chemicals market.
  • The company's P/E ratio of 14.66 suggests a reasonable valuation compared to its earnings.
  • Corbion's profit margin of 5.9% indicates its ability to generate profits from its sales.
  • A gross margin of 26.1% demonstrates the company's efficiency in managing its cost of goods sold.
  • The dividend yield of 3.37% offers investors a steady income stream.

Competitors & Peers

Strengths

  • Leading position in lactic acid and derivatives market.
  • Strong focus on sustainability and renewable resources.
  • Diverse customer base across multiple industries.
  • Global network of sales offices and distributors.

Weaknesses

  • Reliance on raw material prices.
  • Exposure to regulatory changes in the bio-based products market.
  • Limited brand recognition compared to larger chemical companies.
  • Profit margin lower than some competitors.

Catalysts

  • Ongoing: Increasing demand for sustainable food ingredients and bioplastics driving revenue growth.
  • Ongoing: Expansion of production capacity to meet growing demand.
  • Upcoming: Potential new partnerships with pharmaceutical companies to develop innovative drug delivery systems.
  • Ongoing: Continued investment in research and development to create new and improved products.
  • Upcoming: Regulatory changes favoring bio-based products.

Risks

  • Potential: Fluctuations in raw material prices impacting profitability.
  • Potential: Changes in regulatory policies related to bio-based products.
  • Ongoing: Competition from larger chemical companies with greater resources.
  • Potential: Economic downturns affecting demand for specialty chemicals.
  • Ongoing: Currency risk associated with the EUR/USD exchange rate.

Growth Opportunities

  • Expansion in Bioplastics Market: The global bioplastics market is projected to reach $10.7 billion by 2027, growing at a CAGR of 19.5% from 2022. Corbion can capitalize on this growth by increasing its production capacity and developing new bioplastic solutions. The company's lactic acid-based bioplastics offer a sustainable alternative to traditional plastics, appealing to environmentally conscious consumers and businesses. This represents a significant opportunity for revenue growth and market share expansion.
  • Increasing Demand for Sustainable Food Ingredients: The demand for sustainable food ingredients is rising due to growing consumer awareness of health and environmental issues. Corbion's lactic acid-based food ingredients offer natural preservation and taste enhancement, aligning with this trend. By expanding its product portfolio and targeting new food applications, Corbion can tap into this growing market and increase its sales to food manufacturers. This includes leveraging its emulsifiers and functional enzyme blends.
  • Growth in Animal Nutrition Market: The animal nutrition market is experiencing growth due to the increasing demand for meat and dairy products, particularly in developing countries. Corbion's lactic acid-based animal feed additives can improve animal health and productivity, offering a sustainable alternative to traditional feed additives. By expanding its distribution network and targeting key animal nutrition markets, Corbion can capitalize on this growth opportunity and increase its sales to animal feed manufacturers.
  • Penetration of the Pharmaceutical Market: Corbion's high-purity lactic acid and its derivatives are used in various pharmaceutical applications, including drug delivery systems and medical devices. The pharmaceutical market is characterized by high growth and profitability, offering a significant opportunity for Corbion. By developing new pharmaceutical-grade products and partnering with pharmaceutical companies, Corbion can increase its presence in this market and drive revenue growth.
  • Expansion in Home and Personal Care Market: The home and personal care market is increasingly demanding natural and sustainable ingredients. Corbion's lactic acid-based ingredients offer a natural alternative to synthetic ingredients, aligning with this trend. By developing new formulations and partnering with home and personal care brands, Corbion can expand its presence in this market and increase its sales of sustainable ingredients. This includes leveraging its algae ingredients for novel applications.

Opportunities

  • Expansion in the bioplastics market.
  • Increasing demand for sustainable food ingredients.
  • Growth in the animal nutrition market.
  • Penetration of the pharmaceutical market.

Threats

  • Competition from larger chemical companies.
  • Fluctuations in raw material prices.
  • Changes in regulatory policies related to bio-based products.
  • Economic downturns affecting demand for specialty chemicals.

Competitive Advantages

  • Proprietary technology in lactic acid production.
  • Strong relationships with key customers in various industries.
  • Commitment to sustainability and renewable resources.
  • Global network of sales offices and distributors.
  • Focus on innovation and product development.

About CSNVY

Corbion N.V., established in 1919 and headquartered in Amsterdam, Netherlands, has evolved into a prominent player in the specialty chemicals industry. Originally known as CSM N.V., the company rebranded to Corbion N.V. in October 2013, marking a strategic shift towards sustainable ingredient solutions. Corbion specializes in the production and distribution of lactic acid, lactic acid derivatives, emulsifiers, functional enzyme blends, minerals, vitamins, and algae ingredients. These ingredients are derived from renewable resources and cater to a wide array of industries, including food, home and personal care, pharmaceuticals, animal nutrition, medical devices, and bioplastics. Corbion's commitment to sustainability is reflected in its focus on bio-based solutions that address the growing demand for environmentally friendly products. The company operates globally, marketing its products through a network of sales offices and distributors, ensuring a widespread presence and accessibility for its diverse customer base. Corbion's product portfolio includes solutions for food preservation, taste enhancement, and functional performance, as well as ingredients for personal care products, pharmaceuticals, and bioplastics. The company's dedication to innovation and sustainability positions it as a key player in the transition towards a more circular and bio-based economy.

What They Do

  • Produces lactic acid and lactic acid derivatives.
  • Offers emulsifiers for various applications.
  • Develops functional enzyme blends for food and other industries.
  • Provides minerals and vitamins for nutritional applications.
  • Supplies algae ingredients for diverse markets.
  • Creates ingredient solutions from renewable resources.
  • Serves the food, home and personal care, pharmaceutical, and bioplastics markets.

Business Model

  • Develops and manufactures lactic acid-based ingredients.
  • Markets its products through a network of sales offices and distributors.
  • Focuses on providing sustainable solutions to various industries.
  • Invests in research and development to create innovative products.

Industry Context

Corbion N.V. operates within the specialty chemicals industry, a sector characterized by innovation, sustainability, and increasing demand for bio-based solutions. The market is driven by trends such as the growing consumer awareness of environmental issues, stricter regulations on traditional chemicals, and the increasing adoption of bio-plastics and sustainable food ingredients. The competitive landscape includes companies such as ALPKF (Alpek SAB de CV), CUYRF (Kuraray Co. Ltd.), and others that offer similar or alternative solutions. Corbion's focus on lactic acid and its derivatives, along with its commitment to sustainability, positions it as a key player in this evolving market.

Key Customers

  • Food manufacturers seeking natural preservatives and taste enhancers.
  • Home and personal care brands looking for sustainable ingredients.
  • Pharmaceutical companies requiring high-purity ingredients.
  • Animal feed manufacturers seeking additives to improve animal health.
  • Bioplastics producers looking for renewable alternatives to traditional plastics.
AI Confidence: 81% Updated: Mar 16, 2026

Financials

Chart & Info

Corbion N.V. (CSNVY) stock price: Price data unavailable

Latest News

No recent news available for CSNVY.

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CSNVY.

Price Targets

Wall Street price target analysis for CSNVY.

MoonshotScore

38/100

What does this score mean?

The MoonshotScore rates CSNVY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Olivier Rigaud

CEO

Olivier Rigaud serves as the CEO of Corbion N.V., leading a global team of 2383 employees. His career spans various leadership roles in the chemicals and materials industries. He brings extensive experience in strategic planning, operational excellence, and business development. Rigaud's background includes a strong focus on driving sustainable growth and innovation within organizations. His expertise is instrumental in guiding Corbion's strategic direction and expansion into new markets.

Track Record: Under Olivier Rigaud's leadership, Corbion N.V. has focused on expanding its sustainable product portfolio and strengthening its position in the bio-based ingredients market. Key achievements include strategic investments in R&D and capacity expansion to meet the growing demand for sustainable solutions. Rigaud has also overseen the company's efforts to enhance its operational efficiency and improve its financial performance.

Corbion N.V. ADR Information Unsponsored

An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. CSNVY is an ADR, meaning it allows U.S. investors to invest in Corbion N.V. without directly dealing with the Amsterdam stock exchange. The ADR represents a specific number of Corbion's ordinary shares held by a U.S. depositary bank.

  • Home Market Ticker: Euronext Amsterdam, Netherlands
  • ADR Level: 1
  • ADR Ratio: 1:1
  • Home Market Ticker: CSNV
Currency Risk: Investing in CSNVY exposes U.S. investors to currency risk, as the ADR's value is affected by fluctuations in the EUR/USD exchange rate. If the euro weakens against the dollar, the value of CSNVY may decrease, even if Corbion's underlying business performs well. Investors may want to evaluate this currency risk when evaluating the potential returns from CSNVY.
Tax Implications: Dividends paid on CSNVY shares are subject to foreign dividend withholding tax in the Netherlands. The standard withholding tax rate is typically 15%, but this may be reduced depending on the tax treaty between the Netherlands and the United States. U.S. investors may be able to claim a foreign tax credit on their U.S. tax return for the amount of foreign tax withheld.
Trading Hours: Trading hours for CSNVY on the OTC market may not perfectly align with the trading hours of Corbion's primary listing on Euronext Amsterdam. Euronext Amsterdam typically operates from 9:00 AM to 5:30 PM Central European Time (CET), which is 3:00 AM to 11:30 AM Eastern Time (ET). This difference in trading hours may result in periods of limited liquidity for CSNVY.

CSNVY OTC Market Information

The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies trading on this tier often have limited financial disclosure and may not meet the listing requirements of major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity compared to exchange-listed stocks. This tier is also known as the 'Pink Sheets'.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Liquidity for CSNVY on the OTC market is likely to be limited, given its OTC Other tier status. This may result in wider bid-ask spreads and greater difficulty in buying or selling large quantities of shares without significantly impacting the price. Investors should be aware of the potential for price volatility and illiquidity when trading CSNVY on the OTC market.
OTC Risk Factors:
  • Limited financial disclosure.
  • Potential for price manipulation.
  • Higher bid-ask spreads.
  • Lower trading volume.
  • Increased risk of fraud.
Due Diligence Checklist:
  • Verify the company's registration and legal status.
  • Review available financial statements and disclosures.
  • Assess the company's management team and track record.
  • Research the company's industry and competitive landscape.
  • Evaluate the company's business model and growth prospects.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor.
Legitimacy Signals:
  • Established history as Corbion N.V. and formerly CSM N.V.
  • Operations in a regulated industry (specialty chemicals).
  • Presence of a recognized CEO (Olivier Rigaud).
  • Dividend payments indicating financial stability.
  • ADR status providing some level of oversight.

What Investors Ask About Corbion N.V. (CSNVY)

What does Corbion N.V. do?

Corbion N.V. is a global provider of lactic acid and lactic acid derivatives, offering ingredient solutions derived from renewable resources. The company serves diverse markets, including food, home and personal care, pharmaceuticals, animal nutrition, medical devices, and bioplastics. Corbion's products are used for food preservation, taste enhancement, drug delivery, and the production of bioplastics, among other applications. The company's focus on sustainability and innovation positions it as a key player in the transition towards a more circular and bio-based economy.

What do analysts say about CSNVY stock?

Analyst coverage of CSNVY is limited due to its OTC listing. However, key valuation metrics such as the P/E ratio of 14.66 and the dividend yield of 3.37% provide some insight into the company's financial performance. Growth considerations include the increasing demand for sustainable food ingredients and bioplastics, as well as the company's ongoing investments in R&D and capacity expansion. Investors should conduct their own thorough research and consider the risks associated with investing in OTC stocks.

What are the main risks for CSNVY?

The main risks for CSNVY include fluctuations in raw material prices, changes in regulatory policies related to bio-based products, competition from larger chemical companies, and economic downturns affecting demand for specialty chemicals. Additionally, investing in CSNVY on the OTC market carries higher risks due to limited financial disclosure, potential for price manipulation, and lower liquidity. Investors should carefully consider these risks before investing in CSNVY.

How does Corbion N.V. compare to competitors in its industry?

Corbion N.V. distinguishes itself from competitors like Alpek SAB de CV and Kuraray Co. Ltd. through its specific focus on lactic acid and its derivatives, derived from renewable resources. While competitors may offer a broader range of chemical products, Corbion's specialization allows for deep expertise and innovation in its niche. This focus on sustainable, bio-based solutions caters to a growing market segment seeking environmentally friendly alternatives, providing a competitive edge.

What are the key financial metrics investors watch for CSNVY?

For Corbion N.V., investors closely monitor metrics such as revenue growth, profit margins, and return on invested capital (ROIC). Revenue growth indicates the company's ability to expand its market share in the specialty chemicals sector. Profit margins reflect its efficiency in managing costs and generating profits from sales. ROIC assesses the effectiveness of its capital allocation decisions. Given its focus on dividends, dividend yield is also a key metric for investors seeking income.

What are the key factors to evaluate for CSNVY?

Corbion N.V. (CSNVY) currently holds an AI score of 38/100, indicating low score. Key strength: Leading position in lactic acid and derivatives market.. Primary risk to monitor: Potential: Fluctuations in raw material prices impacting profitability.. This is not financial advice.

How frequently does CSNVY data refresh on this page?

CSNVY prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven CSNVY's recent stock price performance?

Recent price movement in Corbion N.V. (CSNVY) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Leading position in lactic acid and derivatives market.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • OTC market data may be less reliable than exchange-listed data.
  • Analyst coverage of CSNVY is limited.
Data Sources

Popular Stocks